Episode Details
Back to Episodes
H5N1 Avian Flu Spreads Globally: Devastating Impact on Animals, Humans, and Agriculture in 2025
Published 7 months ago
Description
Welcome to “H5N1 Global Scan: Avian Flu Worldwide.” I’m your host, bringing you today’s international focus on the global impact of the H5N1 avian influenza virus in 2025.
The highly pathogenic H5N1 virus has swept across the world since 2020, affecting every continent except Australia, and triggering major health and economic repercussions. In the Americas, particularly since 2022, outbreaks have surged—not just among wild birds and poultry but now in mammals including dairy cattle and domestic pets. As of February 2025, 19 countries in this region reported more than 4,700 confirmed animal outbreaks, with the United States alone seeing over 970 dairy herds affected and many human cases linked to direct animal exposure, according to the Pan American Health Organization and World Health Organization reports.
In Europe, the virus remains most prevalent in central and western regions, with 31 countries noting hundreds of outbreaks among wild waterfowl and domestic birds. Human infections in the EU remain rare and have not demonstrated human-to-human transmission, but occupational risk for workers in agriculture and veterinary fields remains an ongoing concern, as noted by public health monitoring organizations. New virus strains have also appeared in domestic cats and wild carnivores, complicating containment efforts.
Turning to Asia, clusters of human cases have emerged in Cambodia, Vietnam, and China, often resulting from direct contact with sick poultry. Genetic sequencing in Southeast Asia found that novel virus reassortments, involving strains native to the region and recent global lineages, have sparked new human infections and demanded increased surveillance. India and China also reported deaths in humans linked to contact with sick birds or contaminated environments, while countries throughout the region continue to grapple with limitations in resources and infrastructure.
Africa has seen repeated outbreaks among poultry farms and wild birds, with less frequent human transmission but significant impacts on local food supplies and rural economies. In the Middle East, surveillance has intensified as bird migration contributes to periodic spread.
Major international research initiatives are collaborating across borders to study these evolving strains and their animal-to-human transmission dynamics. For instance, the FAO and WHO have been investing in genome sequencing programs, risk assessment, and global surveillance networks, while US and European teams have identified new genotypes affecting cattle and pets, helping inform vaccine development.
Speaking of vaccines, the global effort to develop and deploy effective H5N1 vaccines faces challenges. Traditional avian flu vaccines for poultry are used in some Asian countries, but mass production for humans remains limited, with current candidates largely deployed for high-risk groups and emergency stockpiles. Most advanced economies are investing in faster, cross-protective vaccine technologies but remain vigilant for any signs of adaptation that might make H5N1 more transmissible between humans.
Global coordination is ongoing. The WHO emphasizes the critical need for transparent reporting, rapid case investigation, and strong biosecurity on farms, while the FAO supports affected countries with technical assistance and trade guidance. Cross-border outbreaks complicate trade, with several countries banning poultry exports or imposing quarantine zones, causing food price spikes and disrupting international markets.
Comparing national containment approaches, the US and EU focus heavily on animal surveillance, rapid culling, movement restrictions, and public communication. Southeast Asian countries tend to combine vaccination, community-based interventions, and live market controls, while Latin American nations rely on outbreak reporting and animal health services.
That wraps up this
The highly pathogenic H5N1 virus has swept across the world since 2020, affecting every continent except Australia, and triggering major health and economic repercussions. In the Americas, particularly since 2022, outbreaks have surged—not just among wild birds and poultry but now in mammals including dairy cattle and domestic pets. As of February 2025, 19 countries in this region reported more than 4,700 confirmed animal outbreaks, with the United States alone seeing over 970 dairy herds affected and many human cases linked to direct animal exposure, according to the Pan American Health Organization and World Health Organization reports.
In Europe, the virus remains most prevalent in central and western regions, with 31 countries noting hundreds of outbreaks among wild waterfowl and domestic birds. Human infections in the EU remain rare and have not demonstrated human-to-human transmission, but occupational risk for workers in agriculture and veterinary fields remains an ongoing concern, as noted by public health monitoring organizations. New virus strains have also appeared in domestic cats and wild carnivores, complicating containment efforts.
Turning to Asia, clusters of human cases have emerged in Cambodia, Vietnam, and China, often resulting from direct contact with sick poultry. Genetic sequencing in Southeast Asia found that novel virus reassortments, involving strains native to the region and recent global lineages, have sparked new human infections and demanded increased surveillance. India and China also reported deaths in humans linked to contact with sick birds or contaminated environments, while countries throughout the region continue to grapple with limitations in resources and infrastructure.
Africa has seen repeated outbreaks among poultry farms and wild birds, with less frequent human transmission but significant impacts on local food supplies and rural economies. In the Middle East, surveillance has intensified as bird migration contributes to periodic spread.
Major international research initiatives are collaborating across borders to study these evolving strains and their animal-to-human transmission dynamics. For instance, the FAO and WHO have been investing in genome sequencing programs, risk assessment, and global surveillance networks, while US and European teams have identified new genotypes affecting cattle and pets, helping inform vaccine development.
Speaking of vaccines, the global effort to develop and deploy effective H5N1 vaccines faces challenges. Traditional avian flu vaccines for poultry are used in some Asian countries, but mass production for humans remains limited, with current candidates largely deployed for high-risk groups and emergency stockpiles. Most advanced economies are investing in faster, cross-protective vaccine technologies but remain vigilant for any signs of adaptation that might make H5N1 more transmissible between humans.
Global coordination is ongoing. The WHO emphasizes the critical need for transparent reporting, rapid case investigation, and strong biosecurity on farms, while the FAO supports affected countries with technical assistance and trade guidance. Cross-border outbreaks complicate trade, with several countries banning poultry exports or imposing quarantine zones, causing food price spikes and disrupting international markets.
Comparing national containment approaches, the US and EU focus heavily on animal surveillance, rapid culling, movement restrictions, and public communication. Southeast Asian countries tend to combine vaccination, community-based interventions, and live market controls, while Latin American nations rely on outbreak reporting and animal health services.
That wraps up this